| Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005) |
|---|
| 06/29/2006 | US20060142305 N- alpha -(2,4,6-triisopropylphenylsulfonyl)-3-hydroxyamidino-(L)-phenylalanine-4-ethoxycarbonylpiperazinium hydrogen sulfate; N- alpha -(2,4,6-triisopropylphenylsulfonyl)-3-hydroxyguanidino-(L)-phenylalanine-4-ethoxycarbonylpiperazide; urokinase plasminogen activator inhibitor; anticarcinogenic agent |
| 06/29/2006 | US20060142296 4(Phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain or gastrointestinal disorders |
| 06/29/2006 | US20060142267 [6-hydroxy-2-(2-hydroxy-benzyl)-benzo [b]thiophen-3-yl]-[4-(2-piperidin-1-yl-ethoxy)-phenyl]-methanone; [6-hydroxy-2-(2-hydroxy-benzyl)-naphthalen-1-yl]-[4-(2-piperidin-1-yl-ethoxy)-phenyl]-methanone; 6-(2-hydroxy-benzyl)-5-{hydroxy-[4-(2-piperidin-1-yl-ethoxy)-phenyl]-methyl}-naphthalen-2-ol |
| 06/29/2006 | US20060141597 Valency platform molecules comprising aminooxy groups |
| 06/29/2006 | DE102004060074A1 Verfahren zur Herstellung von Onium Alkylsulfaten mit geringem Halogenid-Gehalt A process for the preparation of onium alkylsulfates with low halide content |
| 06/29/2006 | DE102004060073A1 Producing onium tetrafluoroborates useful as ionic liquids comprises reacting an onium halide with a trialkyloxonium, trialkylsulfonium or triphenylcarbonium tetrafluoroborate |
| 06/29/2006 | CA2591793A1 Tetralin and indane derivatives and uses thereof |
| 06/29/2006 | CA2591757A1 Crystal and salt of 1-cyclopropylmethyl-4-[2-(3,3,5,5)-tetramethylcyclohexyl)phenyl]piperazine |
| 06/29/2006 | CA2590246A1 Novel ligands that modulate rar receptors, and use thereof in human medicine and in cosmetics |
| 06/29/2006 | CA2589748A1 Heterocyclic compounds as ccr2b antagonists |
| 06/29/2006 | CA2589367A1 Sulfonyl amino cyclic derivatives and use thereof |
| 06/28/2006 | EP1674459A1 High-purity piperazine pyrophosphate and method for producing same |
| 06/28/2006 | EP1674452A1 Novel 4-phenylamino-benzaldoxime derivative and use thereof as mek inhibitor |
| 06/28/2006 | EP1674096A2 Hypoglycemics comprising organic zinc (II) complexes |
| 06/28/2006 | EP1673384A2 Nitrosated glutamic acid compounds, compositions and methods of use |
| 06/28/2006 | EP1673358A1 Phenylpiperazine cycloalkanol derivatives and methods of their use |
| 06/28/2006 | EP1673357A2 Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain |
| 06/28/2006 | EP1673090A1 Fused-aryl and heteroaryl derivatives and methods of their use |
| 06/28/2006 | EP1673089A2 Phenyl-piperazine derivatives as modulators of muscarinic receptors |
| 06/28/2006 | EP1673084A1 1-2' (1,4'-biperidin-1'-yl)-1-(phenyl)-ethylcyclohexanol derivatives as monoamine reuptake modulators for the treatment of vasomotor symptoms |
| 06/28/2006 | EP1673082A2 Dual alanyl aminopeptidase and dipeptidyl peptidase iv inhibitors for functionally influencing different cells and for treating immunological, inflammatory, neuronal and other diseases |
| 06/28/2006 | EP1673078A2 Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease |
| 06/28/2006 | EP1673059A2 Alkanol and cycloalkanol-amine derivatives and methods of their use |
| 06/28/2006 | EP1389188B1 Method for the production of biperiden ii |
| 06/28/2006 | CN1795183A Hydroxyamidine and hydroxyguanidine compounds as urokinase inhibitors |
| 06/27/2006 | US7067697 introducing a biologically active agent into a cell of a plant or animal comprising: contacting said cell with lipid vesicles comprising amino acid amide lipids in vivo or in vitro; gene therapy |
| 06/27/2006 | US7067665 phenylethoxy-phenyl- or -pyridyl- (acet) amides, N-substituted with pyrimidine ring-containing (tetrahydro)pyridines or phenyl groups; e.g., 3-[2-(2,4-Dichloro-phenyl)-ethoxy]-4-methoxy-N-[4-(pyrimidin-2-ylsulfamoyl)-phenyl]-benzamide; treating cardiovascular disorders such as thromboses and restenoses |
| 06/27/2006 | US7067660 Process for the preparation of pyrazolopyrimidinones |
| 06/27/2006 | US7067553 Thiourea compounds and the pharmaceutical compositions containing the same |
| 06/27/2006 | US7067551 Deacetylase inhibitors |
| 06/27/2006 | US7067539 Cannabinoid receptor ligands |
| 06/27/2006 | US7067517 Use of compounds for decreasing activity of hormone-sensitive lipase |
| 06/27/2006 | US7067510 5-[4-(2-piperidin-1-yl-ethoxy)-phenyl]-5,11-dihydro-6-oxa-12-thia-dibenzo[a,f]azulen-2-ol; 13-[4-(2-piperidin-1-yl-ethoxy)-phenyl]-7,13-dihydro-12-oxa-benzo[4,5]cyclohepta[1,2-a]naphthalen-3-ol or derivatives or salts; for alleviating symptoms of estrogen deprivation, including bone loss |
| 06/27/2006 | US7067501 Phenylsulfanylphenyl and phenyloxyphenyl substituted piperazine compounds; glycine transport inhibitors; for the treatment of psychoses and convulsive disorders: epilepsy, spasticity, and myoclonus |
| 06/27/2006 | US7067119 Using polypeptides |
| 06/27/2006 | CA2251637C Novel substituted [2-(1-piperazinyl)ethoxy]methyl |
| 06/22/2006 | WO2006065706A1 N-biaryl and n-arylheteroaryl 2-substituted piperazine derivatives as modulators of the 5ht2c receptor useful for the treatment of disorders related thereto |
| 06/22/2006 | WO2006065600A2 N-biaryl and n-arylheteroaryl piperazine derivatives as modulators of the 5ht2c receptor useful for the treatment of disorders related thereto |
| 06/22/2006 | WO2006065479A2 Substituted phenols as active agents inhibiting vegf production |
| 06/22/2006 | WO2006063762A1 Dipeptide nitriles |
| 06/22/2006 | WO2006063656A1 Method for producing onium salts comprising alkyl anions or aryl sulfonate anions or alkyl anions or aryl carboxylate anions having a low halide content |
| 06/22/2006 | WO2006063654A1 Method for producing onium alkyl sulfates with a low halogenide content |
| 06/22/2006 | WO2006063653A1 Method for the production of onium salts with tetrafluoroborate anion having a reduced halide content |
| 06/22/2006 | WO2006051314A3 Guanidine derivatives as inhibitors of ddah |
| 06/22/2006 | US20060135770 PARP inhibitors |
| 06/22/2006 | US20060135560 Prevention and treatment of cardiovascular pathologies with tamoxifen analogues |
| 06/22/2006 | US20060135532 Anticoagulants; antithrombotic agents in the treatment and prevention of thrombosis |
| 06/22/2006 | US20060135531 Modulators of dopamine neurotransmission |
| 06/22/2006 | US20060135505 N-(7-hydroxy-5,6,7,8-tetrahydronaphthalen-1-yl)-N'-[3-piperidin-1-yl-4-(trifluoromethyl)benzyl]urea; urinary incontinence, overactive bladder, pain, nerve injury, ischemia, neurodegeneration, stroke, inflammatory disorders, asthma and chronic obstructive pulmonary disease |
| 06/22/2006 | US20060135503 Cyclic amide derivative as monocyte chemotactic protein modulator; prevention and treatment of rheumatoid arthritis, multiple sclerosis, atherosclerosis and asthma; antiinflammatory agents; N-[2-[[(cis) -2-[[1- (4-Chlorophenyl)ethyl]amino]cyclohexyl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide |
| 06/22/2006 | US20060135502 Cyclic derivatives as modulators of chemokine receptor activity |
| 06/22/2006 | US20060135487 Piperazine derivatives and their use as anti-inflammatory agents |
| 06/22/2006 | CA2590780A1 Process for the preparation of onium salts with a tetrafluoroborate anion having a reduced halide content |
| 06/22/2006 | CA2588595A1 N-biaryl and n-arylheteroaryl piperazine derivatives as modulators of the 5ht2c receptor useful for the treatment of disorders related thereto |
| 06/22/2006 | CA2588567A1 N-biaryl and n-arylheteroaryl 2-substituted piperazine derivatives as modulators of the 5ht2c receptor useful for the treatment of disorders related thereto |
| 06/21/2006 | EP1670787A2 Cytokine inhibitors |
| 06/21/2006 | EP1670783A2 Antithrombotic aromatic ethers |
| 06/21/2006 | EP1670775A1 Piperazine subtituted compounds used as calcium channel blockers |
| 06/21/2006 | EP1670774A1 Quinoxaline compounds |
| 06/21/2006 | EP1670761A1 Tetrahydro-naphthalene and urea derivatives |
| 06/21/2006 | EP1670755A2 Pyrovalerone analogs and therapeutic uses thereof |
| 06/21/2006 | EP1670740A2 Clear photopolymerizable systems for the preparation of high thickness coatings |
| 06/21/2006 | EP1229029B1 Process for producing benzylamine compound |
| 06/21/2006 | EP1222179B1 Process for preparing piperazine-substituted aliphatic carboxylates |
| 06/21/2006 | EP1049662B1 Inhibitors of alpha4 mediated cell adhesion |
| 06/21/2006 | CN1791606A Nitrogen-containing monodentate phosphines and their use in catalysis |
| 06/21/2006 | CN1791572A Novel compounds |
| 06/21/2006 | CN1791568A Hsp90 family protein inhibitors |
| 06/21/2006 | CN1789399A Soft compound and use thereof |
| 06/20/2006 | US7064136 Central nervous system disorders; psychological disorders; schizophrenia; antiarthritic agents; Alzheimer's disease; anticancer agents |
| 06/20/2006 | US7064128 Preferentially substituted calcium channel blockers |
| 06/20/2006 | US7064124 nuclear factor (NF); inflammatory diseases, autoimmune diseases and viral diseases; 4-(3,4,5,6-tetramethoxy-2-methylbenzyl)-2-benzyloxybenzoic acid or 4-(5,6-dimethoxy-3-methyl-1,4-benzoquinon-2-yl)methyl-2-benzyloxybenzoic acid, for example |
| 06/20/2006 | US7064123 substituted acetamides; uses for treating diseases including arthritis, muscular dystrophy, inflammation, tumor invasion, glomerulonephritis, malaria, periodontal disease, and metachromatic leukodystrophy |
| 06/15/2006 | WO2006062110A1 Piperazine derivative |
| 06/15/2006 | WO2006061332A1 Gleevec process |
| 06/15/2006 | WO2006044425A3 Ophthalmic compositions for treating ocular hypertension |
| 06/15/2006 | WO2006042103A3 Reversible inhibitors of cathepsin b |
| 06/15/2006 | WO2005113526A3 Metabolites of 4-(3,4-dichloro-phenyl)-2-[2-(4-methyl-piperazin-1-yl)-benzylidene]-thiomorpholin-3-one |
| 06/15/2006 | WO2005089815A3 Radiohalogenated benzamide derivatives and their use in tumor diagnosis and tumor therapy |
| 06/15/2006 | WO2005085188A3 Compounds and methods for anti-tumor therapy |
| 06/15/2006 | US20060128903 Process for the controlled increase in the molecular weight of polyethylenes |
| 06/15/2006 | US20060128704 2-Hydroxy-1,2,3,4-tetrahydronaphthalenes substituted in the 8-position with a biphenylcarbonylamino-, biphenylcarbonylaminoalkyl-, biphenylaminocarbonylamino-, or biphenylaminocarbonylaminoalkyl- group; vanilloid receptor antagonists |
| 06/15/2006 | US20060128690 Amine derivative |
| 06/15/2006 | US20060128662 Novel compounds for treatment of obesity |
| 06/15/2006 | US20060128633 Colchinol derivatives as vascular damaging agents |
| 06/15/2006 | US20060124030 Colored top coat composition and colored top coat film using same |
| 06/15/2006 | US20060124029 Clear paint composition and clear coat film using same |
| 06/15/2006 | US20060123565 Para-phenylenediamine derivatives comprising a cyclic diaza group substituted with a cationic radical, and use of these derivatives for dyeing keratin fibers |
| 06/15/2006 | CA2587928A1 Phenylpiperazines with a combination of affinity for dopamine -d2 receptors and serotonin reuptake sites |
| 06/14/2006 | EP1669345A1 Ester derivative and medicinal use thereof |
| 06/14/2006 | EP1668008A2 Nitrosated ad nitrosylated diuretic compouds, compositions and methods of use |
| 06/14/2006 | EP1667962A1 Aminoalkylamide substituted cyclohexyl derivatives |
| 06/14/2006 | EP1667958A2 Melanin concentrating hormone antagonists |
| 06/14/2006 | EP1667955A2 Cycloalkylidene compounds as modulators of the estrogen receptor |
| 06/14/2006 | EP1667643A2 Nitrosated and nitrosylated cardiovascular compounds, compositions and methods of use |
| 06/14/2006 | EP0966283B1 Pharmaceutical products for curing and preventing diseases resulting from the damaging of the vascular endothelial cells |
| 06/14/2006 | CN1787989A Imino ether derivative compounds and drugs containing the compounds as the active ingredient |
| 06/14/2006 | CN1787818A Amino cyclobutylamide modulators of chemokine receptor activity |
| 06/14/2006 | CN1259307C Acylated indanyl amines and their use as pharmaceuticals |
| 06/13/2006 | US7060821 Osteoclast differentiation inhibitors |